Skip to main content icon/video/no-internet

New Zealand, located in Oceania, is an island nation in the South Pacific Ocean, southeast of Australia. Drug policy in New Zealand is based on the principle of harm minimization and is focused on preventing and reducing the health, social, and economic harms that are linked to drug use. Drug use is viewed as primarily a health issue that should therefore be addressed, at least partially, through health-based responses.

Drug policy in New Zealand supports a balance of measures, including supply control, demand reduction, and harm reduction. New Zealand's existing primary drug law, the Misuse of Drugs Act, is poorly aligned with current drug policy and is in the process of being reviewed.

Current drug policy in New Zealand is set out in the National Drug Policy 2007–2012. This document outlines the government's policy for tobacco, alcohol, illegal and other drugs within a single framework. A National Drug Policy was first adopted in 1998 to set the overall direction for drug policy in New Zealand. Cannabis is the most widely used illegal drug in New Zealand, with approximately 13.3 percent of the population between the ages of 15 and 64 using it annually. Amphetamine, including methamphetamine, use is also relatively high, with 2.3 percent using annually. New Zealand also has among the world's highest rates of ecstasy use. Approximately 2.6 percent of those ages 15 to 64 are annual ecstasy users. The prevalence of cocaine (0.8 percent) and opiate use is relatively low (0.4 percent).

Harm Reduction

The principle of harm reduction or minimization is at the core of drug policy in New Zealand. The overarching goal is to prevent and reduce the health, social, and economic harms that are linked to tobacco, alcohol, illegal and other drug use. The National Drug Policy accepts that drug use is primarily a health issue and should therefore be addressed, at least partially, through health-based responses.

Within the framework provided by the National Drug Policy, central and local government agencies and nongovernmental organizations involved in the alcohol and drug sector set their priorities and develop their work programs. The expectation is that the priorities of all relevant agencies in the sector are aligned with the National Drug Policy and that their work plans implement strategies and measures that support the policy.

The National Drug Policy recognizes that there is a continuum of harm associated with drug use and that there is no single approach or strategy that can, on its own, address the problems. Instead, a range of strategies is needed. This requires the development of specific strategies that are responsive and culturally appropriate in addressing the needs of New Zealand's Maori aboriginal peoples, Pacific peoples, and young people, given the overrepresentation of these groups in many drug-related problems.

Strategies that support harm minimization in New Zealand can be divided into three groups or “pillars,” consistent with the balanced approach to minimizing the harm caused by drugs that has been proposed by the United Nations (UN). These encompass supply control, demand reduction, and problem limitation.

In New Zealand, both the police and customs are engaged in law enforcement that disrupts the illegal importation, manufacture, supply and possession of drugs. Over recent years, supply controls have focused on the importation and distribution of precursor substances like pseudoephedrine, which is used in the manufacture of methamphetamine, and have targeted clandestine methamphetamine labs.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading